4//SEC Filing
TITAN PHARMACEUTICALS INC 4
Accession 0001019687-04-000280
$TTNPCIK 0000910267operating
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 2:15 PM ET
Size
7.1 KB
Accession
0001019687-04-000280
Insider Transaction Report
Form 4
BUCALO LOUIS R MD
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2004-02-09$0.59/sh+81,755$48,235→ 431,986 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-02-09−81,755→ 0 totalExercise: $0.59From: 1994-03-09Exp: 2004-02-09→ Common Stock (81,755 underlying)
Footnotes (1)
- [F1]Not applicable.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000910267
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 2:15 PM ET
- Size
- 7.1 KB